Press Releases August 27, 2026 04:05 PM

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

Resmed to Present at Morgan Stanley Global Healthcare Conference, Showcasing Leadership in Home Healthcare Technology

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
RMD

Resmed announced that its CEO Mick Farrell and CFO Aaron Bloomer will participate in the 24th Annual Morgan Stanley Global Healthcare Conference on September 15, 2026, presenting via webcast to discuss the company’s advances and business outlook. Resmed specializes in AI-powered digital health solutions and cloud-connected devices for home healthcare, focusing on sleep and breathing health worldwide.

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
RMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Resmed executives will attend and present at a prominent healthcare conference, increasing visibility among investors and industry peers.
  • The company emphasizes its leadership in AI-driven digital health technologies and cloud-connected home healthcare devices.
  • Resmed operates in 140 countries, reflecting a broad global footprint in medical technology focused on sleep and breathing health.
  • Sectors impacted include healthcare technology, digital health, medical devices, and AI applications in medicine.

SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed’s webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investorsFor media+1 858.221.3304+1 619.510.1281investorrelations@resmed.comnews@resmed.com



Risks

  • Market and regulatory uncertainties impacting healthcare technology companies like Resmed.
  • Potential competition and innovation pace in digital health and AI-powered medical devices.
  • Dependence on global economic and healthcare spending trends affecting adoption of home healthcare solutions.

More from Press Releases

Amid AI Boom, Verisk Launches New View of U.S. Data Center Exposure, Helping Insurers Assess Growing Concentrations of Risk Sep 3, 2026 Reborn Coffee Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements Sep 3, 2026 HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy Sep 3, 2026 LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China Sep 3, 2026 Ming Shing Group Holdings Limited Announces Closing of the Acquisition of Meals Through Seasons Limited and Issuance of Consideration Shares and Unsecured Convertible Promissory Notes Sep 2, 2026